COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,159 Articles (22,703 medRxiv, 8,456 bioRxiv)

Most recent first Previous |  Page 2743: Articles 27421-27430  | Next

Assessment of service availability and Infection prevention measures in hospitals of Nepal during the transition phase of COVID-19 case surge
Bhattarai, S., Dhungana, J., Ensor, T., Shrestha, U. B.
10.1101/2020.05.13.20097675 — Posted: 2020-05-19
SARS-CoV-2 seroconversion in health care workers
Shields, A. M., Faustini, S. E., Perez-Toledo, M., Jossi, S., Aldera, E. L., Allen, J. D., Al-Taei, S., Backhouse, C., Bosworth, A., Dunbar, L., Ebanks, D., Emmanuel, B., Grey, J., Kidd, I. M., McGinnell, G., McLoughlin, D., Morley, G., O'Neill, J., Papakonstantinou, D., Pickles, O., Poxon, C., Richter, M., Walker, E., Wanigasooriya, K., Watanabe, Y., Whalley, C., Zielinska, A. E., Crispin, M., Wraith, D. C., Beggs, A. D., Cunningham, A. F., Drayson, M. T., Richter, A. G.
10.1101/2020.05.18.20105197 — Posted: 2020-05-19
COVID-19: disease pathways and gene expression changes predict methylprednisolone can improve outcome in severe cases
Draghici, S., Nguyen, T.-M., Sonna, L. A., Ziraldo, C., Vanciu, R. L., Fadel, R., Morrison, A., Ramesh, M., Mor, G.
10.1101/2020.05.06.20076687 — Posted: 2020-05-19
Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers with the Risk of Hospitalization and Death in Hypertensive Patients with Coronavirus Disease-19
Khera, R., Clark, C., Lu, Y., Guo, Y., Ren, S., Truax, B., Spatz, E. S., Murugiah, K., Lin, Z., Omer, S. B., Vojta, D., Krumholz, H. M.
10.1101/2020.05.17.20104943 — Posted: 2020-05-19
COVID-19 Pandemic: Is Chronic Inflammation a Major Cause of Death?
Tskhay, A., Yezhova, A., Alibek, K.
10.1101/2020.05.12.20099572 — Posted: 2020-05-19
High speed large scale automated isolation of SARS-CoV-2 from clinical samples using miniaturized co-culture coupled with high content screening
Francis, R., Le Bideau, M., Jardot, P., Grimaldier, C., Raoult, D., Bou Khalil, J. Y., La Scola, B.
10.1101/2020.05.14.097295 — Posted: 2020-05-19
Temporal and spatial characteristics of the spread of COVID-19 in Rio de Janeiro state and city
Ferreira, D., Ferreira, P., Oliveira, P., Ribeiro, J., Goncalves, E., Papa, A.
10.1101/2020.05.13.20101113 — Posted: 2020-05-19
Off-Label Real World Experience Using Tocilizumab for Patients Hospitalized with COVID-19 Disease in a Regional Community Health System: A Case-Control Study
Ramaswamy, M., Mannam, P., Comer, R., Sinclair, E., McQuaid, D. B., Schmidt, M. L.
10.1101/2020.05.14.20099234 — Posted: 2020-05-19
Hydroxychloroquine in COVID-19: A systematic review and meta-analysis
Chacko, J., Brar, G., Premkumar, R.
10.1101/2020.05.14.20101774 — Posted: 2020-05-19 Discussion: Onsite
Semantic and geographical analysis of Covid-19 trials reveals a fragmented clinical research landscape likely to impair informativeness.
Tini, G., Duso, B. A., Bellerba, F., Corso, F., Gandini, S., Minucci, S., Pelicci, P., Mazzarella, L.
10.1101/2020.05.14.20101758 — Posted: 2020-05-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).